- Home
- ELDN vs AIRS Comparison
ELDN vs AIRS Comparison
Compare ELDN & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- AIRS
- Stock Information
- Founded
- ELDN 2004
- AIRS 2012
- Country
- ELDN United States
- AIRS United States
- Employees
- ELDN N/A
- AIRS N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- AIRS Medical/Nursing Services
- Sector
- ELDN Health Care
- AIRS Health Care
- Exchange
- ELDN Nasdaq
- AIRS Nasdaq
- Market Cap
- ELDN 202.4M
- AIRS 166.3M
- IPO Year
- ELDN N/A
- AIRS 2021
- Fundamental
- Price
- ELDN $2.73
- AIRS $8.11
- Analyst Decision
- ELDN Strong Buy
- AIRS Hold
- Analyst Count
- ELDN 2
- AIRS 3
- Target Price
- ELDN $12.50
- AIRS $3.75
- AVG Volume (30 Days)
- ELDN 998.5K
- AIRS 824.6K
- Earning Date
- ELDN 11-11-2025
- AIRS 11-07-2025
- Dividend Yield
- ELDN N/A
- AIRS N/A
- EPS Growth
- ELDN N/A
- AIRS N/A
- EPS
- ELDN 0.21
- AIRS N/A
- Revenue
- ELDN N/A
- AIRS $165,109,000.00
- Revenue This Year
- ELDN N/A
- AIRS N/A
- Revenue Next Year
- ELDN N/A
- AIRS $5.14
- P/E Ratio
- ELDN $12.80
- AIRS N/A
- Revenue Growth
- ELDN N/A
- AIRS N/A
- 52 Week Low
- ELDN $2.32
- AIRS $1.53
- 52 Week High
- ELDN $5.54
- AIRS $9.20
- Technical
- Relative Strength Index (RSI)
- ELDN 54.22
- AIRS 67.50
- Support Level
- ELDN $2.48
- AIRS $7.44
- Resistance Level
- ELDN $2.71
- AIRS $8.44
- Average True Range (ATR)
- ELDN 0.17
- AIRS 0.62
- MACD
- ELDN 0.04
- AIRS 0.11
- Stochastic Oscillator
- ELDN 60.95
- AIRS 85.05
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.